Intersession Processes in Psychotherapeutic Treatments Using an Ecological Momentary Assessment Approach (ISA-Bell)
ISA-Bell
1 other identifier
interventional
84
1 country
1
Brief Summary
The effects of a monitoring intervention as an add-on to face-to-face Cognitive Behavioral Therapy (CBT) for depression are assessed in this randomised trial. Monitoring consists of Ecological Momentary Assessment (EMA) of symptoms and inter-session processes via mobile phones. Twenty sessions of face-to-face CBT + EMA are compared to twenty sessions of face-to-face CBT (treatment as usual, TAU). 84 patients with mild to moderate depression will be randomised to CBT + EMA or to TAU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Nov 2022
Longer than P75 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2022
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
June 25, 2025
June 1, 2025
3.6 years
August 18, 2022
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Health Questionnaire (PHQ-9)
Participant-reported measure assessing depressive symptomatology. The total score of this nine-item scale ranges from 0-27, with higher scores indicating greater depression-symptom severity.
4-month follow-up
Secondary Outcomes (12)
Patient Health Questionnaire (PHQ-9)
Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up
Beck's Depression Inventory (BDI-II)
Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up
Certainty About Mental States Questionnaire (CAMSQ)
Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up
Dysfunctional Attitude Scale (DAS-18A)
Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up
Depression-Specific Self-Efficacy Expectation Questionnaire (DSWE)
Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up
- +7 more secondary outcomes
Study Arms (2)
Cognitive Behavior Therapy + Ecological Momentary Assessment (CBT + EMA)
EXPERIMENTALCognitive Behavior Therapy + Ecological Momentary Assessment
Treatment as Usual (TAU)
ACTIVE COMPARATORCognitive Behavioural Therapy (Treatment as Usual)
Interventions
20 sessions of face-to-face, individual CBT
Two four-week blocks of twice daily ecological momentary assessment (EMA) of symptoms and inter-session processes
Eligibility Criteria
You may qualify if:
- ICD-10 diagnosis of mild or moderate depression, first or recurrent episode (F32.0, F32.1, F33.0, F33.1)
- PHQ-9 ≥ 5
- Possession of smartphone with internet access
- Signed informed consent
You may not qualify if:
- Acute or past suicidality; self-reported
- Acute addiction (F10 - F19)
- Dysthymia (F34.1), postpartum depression, or severe depression (F32.3; F33.3)
- PHQ-9 \> 20
- Depression not main mental health concern
- Planned onset or planned change in antidepressant medication
- History of psychotic symptoms, bipolar disorder, personality disorders, or organic brain disorders
- Cognitive impairment or physical disability that would hinder psychotherapy or the use of a smartphone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Birgit Watzkelead
- Universität Tübingencollaborator
Study Sites (1)
Psychotherapeutisches Zentrum Universität Zürich
Zurich, Canton of Zurich, 8032, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Birgit Watzke, PhD
University of Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- As is common in psychotherapy research, participants and care providers cannot be blinded to the intervention. Only subjective outcomes (i.e., participant-rated) are assessed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
August 18, 2022
First Posted
September 23, 2022
Study Start
November 1, 2022
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
June 25, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share